Novo Nordisk Pharmaceuticals Pty Ltd—Mixtard 30/70 Innolet Human insulin 1001U/mL Injection multidose cartridge

Identifying features

(TGA R2004/1222)

What are the defects?

Two batches of this product may have been exposed to frost during distribution to Western Australia. There is a possibility that the delivery mechanism may become jammed and unable to deliver insulin.

What are the hazards?

Contamination.

What should consumers do?

Consumers to return the product to the place of purchase.

Supplier
Novo Nordisk Pharmaceuticals Pty Ltd
Where the product was sold
Western Australia

Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category